Skip to main content

Obesity Management Market Synopsis, Diagnosis, Treatment and Technology Report 2020

Obesity Management Market for weight loss and diet Insights 2019 by Type [Medication (Orlistat, Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone and Liraglutide) and Surgery (Laparoscopic Adjustable Gastric Band, Gastric Sleeve and Gastric Bypass)] and Regional Analysis, size, Share, Technology, Growth Trends  and Forecast To 2025.
The “Obesity Management Market size is expected to register 8.4% CAGR, expected to be valued at USD 9.34 Billion in 2025.”, states the latest Market Research Future (MRFR) report.
Obesity Management Market Overview
Obesity is a chronic condition that is characterized by excessive storage and accumulation of fats in the body. It is measured by the body mass index (BMI). Obesity, along with affecting the appearance of a person also results in chronic diseases. Obesity management includes therapies, products, and services that help in reducing and managing weight in those suffering from obesity.
Key Players 
Key players have used different strategies to create a niche in the market
such as mergers and acquisitions, expansions, partnerships and more. These are the Notable players profiled in the obesity management market report:
  • Pfizer Inc. (US)
  • and Merck Sharp & Dohme Corp.
  • subsidiary of Merck & Co. Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Herbalife Ltd. (US)
  • Apollo Endosurgery (US)
  • AstraZeneca (UK)
  • Ethicon Inc. (US)
  • and Others.
Obesity Management Market Segmentation
The Market Research Future report provides an all-inclusive segmental analysis of the obesity management market on the basis of lifestyle changes, surgery, and prescription.
  • the obesity management market is segmented By prescription,
    • liraglutide (Saxenda)
    • bupropion and naltrexone (Contrave)
    • phentermine and topiramate (Qsymia)
    • lorcaserin (Belvig)
    • orlistat (Xenical)
    • and others.
  • the obesity management market is segmented By surgery,
    • biliopancreatic diversion with dietary switch
    • laparoscopic adjustable gastric banding
    • gastric bypass surgery
    • and Others
  • the obesity management market is segmented By lifestyle changes,
    • exercise
    • dietary changes
    • and others.
Access the Premium Research Details along with Complete TOC@ https://www.marketresearchfuture.com/reports/obesity-management-market-2690
Industry News 
October 2019: International and local, regional faculty of multi-disciplinary experts recently gathered in Abu Dhabi for the 2019 UAE Obesity Conference for discussing and sharing latest trends in obesity management and treatment under the theme titled “It’s time to act upon obesity.” There were presentations for raising obesity pandemic awareness and its associated diseases. Participants analyzed obesity challenges, childhood obesity, and surgical and medical management of obesity.  
LIST OF FIGURES
FIGURE 1 RESEARCH PROCES
FIGURE 2 MARKET STRUCTURE OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 3 MARKET DYNAMICS OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 4 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY TYPE, 2018 (%)
FIGURE 5 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 7 AMERICAS: OBESITY MANAGEMENT MARKET SHARE BY REGION, 2018 (%)
FIGURE 6 NORTH AMERICA: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 7 EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 8 WESTERN EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 9 ASIA-PACIFIC: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
Continued…
By region, the obesity management market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Comments

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...